Health and economic impacts of non-communicable diseases on women in Mexico to be explored through new collaboration

The 20-month project, which is funded by the Mexican Association of Pharmaceutical Research (AMIIF), employs mixed methods to deliver evidence-based insights into the drivers and characteristics of health inequities, particularly in relation to gender, as a consequence of NCDs. Women’s and patient’s voices, community members, and advocacy groups, as well as national and international experts, will be involved throughout the research process and guided by an expert advisory committee. Research outputs will include analyses of financial risk, lost productivity, and policy enablers, and will be of relevance not just to Mexico but to similar countries and contexts.